NASDAQ:IRTC iRhythm Technologies (IRTC) Stock Forecast, Price & News $119.30 -1.64 (-1.36%) (As of 05/26/2023 ET) Add Compare Share Share Today's Range$118.71▼$124.8050-Day Range$115.05▼$139.7052-Week Range$85.74▼$164.69Volume178,028 shsAverage Volume287,109 shsMarket Capitalization$3.64 billionP/E RatioN/ADividend YieldN/APrice Target$154.40 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media iRhythm Technologies MarketRank™ ForecastAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside29.4% Upside$154.40 Price TargetShort InterestBearish7.38% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.25Based on 8 Articles This WeekInsider TradingSelling Shares$1.83 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($3.11) to ($2.22) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.05 out of 5 starsMedical Sector589th out of 1,018 stocksSurgical & Medical Instruments Industry64th out of 105 stocks 3.4 Analyst's Opinion Consensus RatingiRhythm Technologies has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 8 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $154.40, iRhythm Technologies has a forecasted upside of 29.4% from its current price of $119.30.Amount of Analyst CoverageiRhythm Technologies has only been the subject of 4 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.38% of the outstanding shares of iRhythm Technologies have been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 6.7.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 1.35%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IRTC. Previous Next 3.5 News and Social Media Coverage News SentimentiRhythm Technologies has a news sentiment score of 1.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for iRhythm Technologies this week, compared to 3 articles on an average week.Search Interest3 people have searched for IRTC on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,831,058.00 in company stock.Percentage Held by InsidersOnly 0.43% of the stock of iRhythm Technologies is held by insiders.Percentage Held by Institutions98.96% of the stock of iRhythm Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for iRhythm Technologies are expected to grow in the coming year, from ($3.11) to ($2.22) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -34.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -34.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 16.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About iRhythm Technologies (NASDAQ:IRTC) StockiRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.Read More Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IRTC Stock News HeadlinesMay 27, 2023 | finance.yahoo.comInvestors push iRhythm Technologies (NASDAQ:IRTC) 6.9% lower this week, company's increasing losses might be to blameMay 26, 2023 | msn.comiRhythm: Revolutionizing Arrhythmia Detection With AI And Machine LearningMay 27, 2023 | Behind the Markets (Ad)[BREAKING] Small Firm Develops World's First Anti-Aircraft LaserSmall cap wins $1.65 billion contract to make them. GlobeNewswire says this is a $51.1 Billion market by 2026. See why this stock could soar 2,476% >>>May 24, 2023 | finance.yahoo.comiRhythm Technologies to Present at the William Blair 43rd Annual Growth Stock ConferenceMay 24, 2023 | finance.yahoo.comiRhythm Technologies to Present at the William Blair 43rd Annual Growth Stock ConferenceMay 22, 2023 | finance.yahoo.comNew Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable ArrhythmiasMay 17, 2023 | americanbankingnews.comiRhythm Technologies, Inc. (NASDAQ:IRTC) to Post Q2 2023 Earnings of ($0.75) Per Share, William Blair ForecastsMay 11, 2023 | americanbankingnews.comStockNews.com Lowers iRhythm Technologies (NASDAQ:IRTC) to SellMay 27, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Missile" to Replace Nuclear MissilesCBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!May 8, 2023 | americanbankingnews.comVNET Group Reaffirms "Maintains" Rating for iRhythm Technologies (NASDAQ:IRTC)May 8, 2023 | americanbankingnews.comiRhythm Technologies (NASDAQ:IRTC) Receives "Maintains" Rating from VNET GroupMay 8, 2023 | americanbankingnews.comiRhythm Technologies (NASDAQ:IRTC) Given "Maintains" Rating at VNET GroupMay 8, 2023 | americanbankingnews.comiRhythm Technologies (NASDAQ:IRTC) Price Target Raised to $151.00May 8, 2023 | americanbankingnews.comAnalyzing INVO Bioscience (NASDAQ:INVO) and iRhythm Technologies (NASDAQ:IRTC)May 5, 2023 | marketwatch.com8-K: iRhythm Technologies, Inc.May 5, 2023 | markets.businessinsider.comWhat 9 Analyst Ratings Have To Say About iRhythm TechnologiesMay 5, 2023 | msn.comNeedham Maintains iRhythm Technologies (IRTC) Buy RecommendationMay 5, 2023 | msn.comCitigroup Maintains iRhythm Technologies (IRTC) Neutral RecommendationMay 5, 2023 | americanbankingnews.comCitigroup Increases iRhythm Technologies (NASDAQ:IRTC) Price Target to $135.00May 5, 2023 | americanbankingnews.comiRhythm Technologies (NASDAQ:IRTC) PT Raised to $135.00 at CitigroupMay 5, 2023 | americanbankingnews.comiRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Average Rating of "Moderate Buy" from AnalystsMay 5, 2023 | markets.businessinsider.comBTIG Sticks to Its Buy Rating for Irhythm Technologies (IRTC)May 4, 2023 | msn.comiRhythm Technologies: Q1 Earnings InsightsMay 4, 2023 | finance.yahoo.comiRhythm Technologies Announces First Quarter 2023 Financial ResultsMay 3, 2023 | americanbankingnews.comiRhythm Technologies (IRTC) Scheduled to Post Earnings on ThursdayMay 2, 2023 | americanbankingnews.comiRhythm Technologies, Inc. (NASDAQ:IRTC) Short Interest UpdateApril 26, 2023 | seekingalpha.comiRhythm: AI Products May Be Better Than Cardiologists And Stock Looks CheapSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IRTC Company Calendar Last Earnings5/04/2023Today5/27/2023Next Earnings (Estimated)8/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:IRTC CUSIPN/A CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees1,793Year FoundedN/APrice Target and Rating Average Stock Price Forecast$154.40 High Stock Price Forecast$190.00 Low Stock Price Forecast$130.00 Forecasted Upside/Downside+29.4%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)($3.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-116,150,000.00 Net Margins-24.34% Pretax Margin-24.27% Return on Equity-43.22% Return on Assets-23.41% Debt Debt-to-Equity RatioN/A Current Ratio3.10 Quick Ratio2.90 Sales & Book Value Annual Sales$410.92 million Price / Sales8.85 Cash FlowN/A Price / Cash FlowN/A Book Value$7.28 per share Price / Book16.39Miscellaneous Outstanding Shares30,470,000Free Float30,340,000Market Cap$3.64 billion OptionableOptionable Beta1.41 Key ExecutivesQuentin S. BlackfordPresident, Chief Executive Officer & DirectorBrice BobzienChief Financial OfficerMark J. DayChief Technology OfficerMintu TurakhiaChief Medical & Scientific OfficerReyna M. FernandezChief Human Resources Officer & Executive VPKey CompetitorsInari MedicalNASDAQ:NARIHaemoneticsNYSE:HAEIntegra LifeSciencesNASDAQ:IARTICU MedicalNASDAQ:ICUIGlaukosNYSE:GKOSView All CompetitorsInsiders & InstitutionsProShare Advisors LLCSold 333 shares on 5/26/2023Ownership: 0.012%Ameriprise Financial Inc.Bought 4,810 shares on 5/22/2023Ownership: 0.244%JPMorgan Chase & Co.Bought 25,000 shares on 5/18/2023Ownership: 0.000%Rockefeller Capital Management L.P.Bought 865 shares on 5/17/2023Ownership: 0.009%Snowden Capital Advisors LLCBought 240 shares on 5/16/2023Ownership: 0.024%View All Insider TransactionsView All Institutional Transactions IRTC Stock - Frequently Asked Questions Should I buy or sell iRhythm Technologies stock right now? 10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" IRTC shares. View IRTC analyst ratings or view top-rated stocks. What is iRhythm Technologies' stock price forecast for 2023? 10 equities research analysts have issued 1 year target prices for iRhythm Technologies' stock. Their IRTC share price forecasts range from $130.00 to $190.00. On average, they expect the company's stock price to reach $154.40 in the next year. This suggests a possible upside of 29.4% from the stock's current price. View analysts price targets for IRTC or view top-rated stocks among Wall Street analysts. How have IRTC shares performed in 2023? iRhythm Technologies' stock was trading at $93.67 on January 1st, 2023. Since then, IRTC stock has increased by 27.4% and is now trading at $119.30. View the best growth stocks for 2023 here. When is iRhythm Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our IRTC earnings forecast. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies, Inc. (NASDAQ:IRTC) issued its earnings results on Thursday, May, 4th. The company reported ($1.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.80) by $0.49. The business earned $111.44 million during the quarter, compared to analyst estimates of $107.57 million. iRhythm Technologies had a negative net margin of 24.34% and a negative trailing twelve-month return on equity of 43.22%. What ETFs hold iRhythm Technologies' stock? ETFs with the largest weight of iRhythm Technologies (NASDAQ:IRTC) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), ROBO Global Robotics & Automation ETF (ROBO), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Healthcare Technology and Innovation ETF (HTEC), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Principal Healthcare Innovators ETF (BTEC) and SPDR S&P Kensho New Economies Composite ETF (KOMP). What guidance has iRhythm Technologies issued on next quarter's earnings? iRhythm Technologies issued an update on its FY 2023 earnings guidance on Friday, April, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $475.00 million-$485.00 million, compared to the consensus revenue estimate of $482.18 million. What is Kevin M. King's approval rating as iRhythm Technologies' CEO? 20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA). When did iRhythm Technologies IPO? (IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. What is iRhythm Technologies' stock symbol? iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC." Who are iRhythm Technologies' major shareholders? iRhythm Technologies' stock is owned by a number of institutional and retail investors. Top institutional investors include Sands Capital Management LLC (7.94%), BlackRock Inc. (7.45%), FMR LLC (7.39%), Artisan Partners Limited Partnership (4.51%), Mackenzie Financial Corp (4.06%) and Blair William & Co. IL (3.31%). Insiders that own company stock include Daniel G Wilson, David A Vort, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy, Quentin S Blackford and Raymond W Scott. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is iRhythm Technologies' stock price today? One share of IRTC stock can currently be purchased for approximately $119.30. How much money does iRhythm Technologies make? iRhythm Technologies (NASDAQ:IRTC) has a market capitalization of $3.64 billion and generates $410.92 million in revenue each year. The company earns $-116,150,000.00 in net income (profit) each year or ($3.47) on an earnings per share basis. How many employees does iRhythm Technologies have? The company employs 1,793 workers across the globe. How can I contact iRhythm Technologies? iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The official website for the company is www.irhythmtech.com. The company can be reached via phone at (415) 632-5700 or via email at investors@irhythmtech.com. This page (NASDAQ:IRTC) was last updated on 5/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.